The X chromosome and immune associated genes

Journal of Autoimmunity

Volumn 38, Issue 2-3, 2012, Pages

  Bianchi, Ilaria ^a   Lleo, Ana ^a,b   Gershwin, M Eric ^c   Invernizzi, Pietro ^a,c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Etiopathogenesis; Female preponderance; Genetic factors; Sex chromosomes

Indexed keywords

CD11 ANTIGEN; CD40 LIGAND; CD70 ANTIGEN; MICRORNA;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CHROMOSOME DELETION X; CHROMOSOME INACTIVATION; CHROMOSOME MUTATION; GENE DOSAGE; GENETIC PREDISPOSITION; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HEREDITY; HETEROCHROMATIN; HUMAN; HYPER IGM SYNDROME; IMMUNE RESPONSE GENE; IMMUNOREGULATION; IPEX SYNDROME; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOSOMY X; MOSAICISM; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TURNER SYNDROME; WISKOTT ALDRICH SYNDROME; X CHROMOSOME; X CHROMOSOME INACTIVATION; X LINKED SEVERE COMBINED IMMUNODEFICIENCY; Y CHROMOSOME;

AUTOIMMUNE DISEASES; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; GENES, X-LINKED; HUMANS; IMMUNITY; MALE; MICRORNAS; X CHROMOSOME INACTIVATION;

EID: 84858750174     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.11.012     Document Type: Article

References (98)

1. Selmi C. Autoimmunity in 2010. Autoimmun Rev 2011, 10:725-732.
2. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16.
3. Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 2009, 33:1-2.
4. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009, 33:290-299.
5. Rose N.R., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993, 14:426-430.
6. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997, 84:223-243.
7. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007, 29:1-9.
8. Myers R.P., Shaheen A.A., Fong A., Burak K.W., Wan A., Swain M.G., et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology 2009, 50:1884-1892.
9. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7:626-630.
10. Davies A.J. Immunological tolerance and the autoimmune response. Autoimmun Rev 2008, 7:538-543.
11. Boscolo P., Youinou P., Theoharides T.C., Cerulli G., Conti P. Environmental and occupational stress and autoimmunity. Autoimmun Rev 2008, 7:340-343.
12. Morahan G., Peeva V., Mehta M., Williams R. Systems genetics can provide new insights in to immune regulation and autoimmunity. J Autoimmun 2008, 31:233-236.
13. Jacobson E.M., Huber A., Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008, 30:58-62.
14. McCluskey J., Peh C.A. The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenet 1999, 1:3-20.
15. Etzensperger R., McMahon R.M., Jones E.Y., Fugger L. Dissection of the multiple sclerosis associated DR2 haplotype. J Autoimmun 2008, 31:201-207.
16. Baschal E.E., Eisenbarth G.S. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun 2008, 31:1-6.
17. Jacobson E.M., Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 2007, 28:85-98.
18. Castro J., Balada E., Ordi-Ros J., Vilardell-Tarres M. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 2008, 7:345-351.
19. Laakso S.M., Laurinolli T.T., Rossi L.H., Lehtoviita A., Sairanen H., Perheentupa J., et al. Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J Autoimmun 2011, 35:351-357.
20. Hardy J., Singleton A. Genomewide association studies and human disease. N Engl J Med 2009, 360:1759-1768.
21. Lettre G., Rioux J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008, 17:R116-R121.
22. Schaschl H., Aitman T.J., Vyse T.J. Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol 2009, 156:12-16.
23. Fernando M.M., Stevens C.R., Walsh E.C., De Jager P.L., Goyette P., Plenge R.M., et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008, 4:e1000024.
24. Lessard CJ, Ice JA, Adrianto I, Wiley GB, Kelly JA, Gaffney PM, Montgomery CG, Moser KL The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun Rev, 2011 Oct 7 [Epub ahead of print].
25. Fathman C.G., Soares L., Chan S.M., Utz P.J. An array of possibilities for the study of autoimmunity. Nature 2005, 435:605-611.
26. Li H.S., Ligons D.L., Rose N.R. Genetic complexity of autoimmune myocarditis. Autoimmun Rev 2008, 7:168-173.
27. Carneiro-Sampaio M., Coutinho A. Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies. Adv Immunol 2007, 95:51-82.
28. Etzioni A. Immune deficiency and autoimmunity. Autoimmun Rev 2003, 2:364-369.
29. Notarangelo L.D., Gambineri E., Badolato R. Immunodeficiencies with autoimmune consequences. Adv Immunol 2006, 89:321-370.
30. Pessach I.M., Notarangelo L.D. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun 2009, 33:17-24.
31. Lyon M.F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 1961, 190:372-373.
32. Sawalha A.H., Harley J.B., Scofield R.H. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 2009, 33:31-34.
33. Libert C., Dejager L., Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010, 10:594-604.
34. Beck-Peccoz P., Persani L. Premature ovarian failure. Orphanet J Rare Dis 2006, 1:9.
35. Persani L., Rossetti R., Cacciatore C., Bonomi M. Primary Ovarian Insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009, 33:35-41.
36. Milkiewicz P., Heathcote J. Can Turner syndrome teach us about the pathogenesis of chronic cholestasis?. Hepatology 2004, 40:1226-1228.
37. Ranke M.B., Saenger P. Turner's syndrome. Lancet 2001, 358:309-314.
38. Larizza D., Calcaterra V., Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 2009, 33:25-30.
39. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004, 363:533-535.
40. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005, 175:575-578.
41. Juran B.D., Lazaridis K.N. Update on the genetics and genomics of PBC. J Autoimmun 2010, 35:181-187.
42. Dieude P., Boileau C., Allanore Y. Immunogenetics of systemic sclerosis. Autoimmun Rev 2011, 10:282-290.
43. Invernizzi P., Miozzo M., Oertelt-Prigione S., Meroni P.L., Persani L., Selmi C., et al. X monosomy in female systemic lupus erythematosus. Ann NY Acd Sci 2007, 11:56-62.
44. Gualtierotti R., Biggioggero M., Penatti A.E., Meroni P.L. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010, 10:3-7.
45. Dorshkind K., Montecino-Rodriguez E., Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat Rev Immunol 2009, 9:57-62.
46. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404.
47. Wilson M.A., Makova K.D. Evolution and survival on eutherian sex chromosomes. PLoS Genet 2009, 5:e1000568.
48. Soulat D., Burckstummer T., Westermayer S., Goncalves A., Bauch A., Stefanovic A., et al. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. Embo J 2008, 27:2135-2146.
49. Brooks W.H. X chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol 2010, 39:20-29.
50. Invernizzi P., Pasini S., Selmi C., Miozzo M., Podda M. Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 2008, 41:272-277.
51. Wong C.C., Caspi A., Williams B., Houts R., Craig I.W., Mill J. A longitudinal twin study of skewed X chromosome-inactivation. PLoS One 2011, 6:e17873.
52. Chagnon P., Provost S., Belisle C., Bolduc V., Gingras M., Busque L. Age-associated skewing of X-inactivation ratios of blood cells in normal females: a candidate-gene analysis approach. Exp Hematol 2005, 33:1209-1214.
53. Brown C.J., Robinson W.P. The causes and consequences of random and non-random X chromosome inactivation in humans. Clin Genet 2000, 58:353-363.
54. Grolleau-Julius A., Ray D., Yung R.L. The role of epigenetics in aging and autoimmunity. Clin Rev Allergy Immunol 2010, 39:42-50.
55. Stewart J.J. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 1998, 19:352-357.
56. Huang Q., Parfitt A., Grennan D.M., Manolios N. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity 1997, 26:85-93.
57. Chitnis S., Monteiro J., Glass D., Apatoff B., Salmon J., Concannon P., et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2000, 2:399-406.
58. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
59. Zhao M., Sun Y., Gao F., Wu X., Tang J., Yin H., et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun 2010, 35:58-69.
60. Patel D.R., Richardson B.C. Epigenetic mechanisms in lupus. Curr Opin Rheumatol 2010, 22:478-482.
61. Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L, et al. IgM levels inversely correlate with cd40l promoter methylation in patients with primary biliary cirrhosis Hepatology, 2011 Aug 24. [Epub ahead of print]. doi:10.1002/hep.24630.
62. Ozbalkan Z., Bagislar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570.
63. Uz E., Loubiere L.S., Gadi V.K., Ozbalkan Z., Stewart J., Nelson J.L., et al. Skewed X-Chromosome inactivation in scleroderma. Clin Rev Allergy Immunol 2007, 34:352-355.
64. Ozcelik T. X chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol 2008, 34:348-351.
65. Uz E., Mustafa C., Topaloglu R., Bilginer Y., Dursun A., Kasapcopur O., et al. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:3410-3412.
66. Brix T.H., Hegedus L. Twins as a tool for evaluating the influence of genetic susceptibility in thyroid autoimmunity. Ann Endocrinol (Paris) 2011, 72:103-107.
67. Brix T.H., Knudsen G.P., Kristiansen M., Kyvik K.O., Orstavik K.H., Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 2005, 90:5949-5953.
68. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 2006, 14:791-797.
69. Yin X., Latif R., Tomer Y., Davies T.F. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann N Y Acad Sci 2007, 1110:193-200.
70. Rose N.R. The genetics of autoimmune thyroiditis: the first decade. J Autoimmun 2011, 37:88-94.
71. Knudsen G.P., Harbo H.F., Smestad C., Celius E.G., Akesson E., Oturai A., et al. X chromosome inactivation in females with multiple sclerosis. Eur J Neurol 2007, 14:1392-1396.
72. Miozzo M., Selmi C., Gentilin B., Grati F.R., Sirchia S., Oertelt S., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007, 46:456-462.
73. Mitchell M.M., Lleo A., Zammataro L., Mayo M.J., Invernizzi P., Bach N., et al. Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 2011, 6:95-102.
74. Brooks W.H., Le Dantec C., Pers J.O., Youinou P., Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010, 34:J207-J219.
75. Notarangelo L.D. Primary immunodeficiencies. J Allergy Clin Immunol 2010, 125:S182-S194.
76. Bussone G., Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev 2009, 8:332-336.
77. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
78. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P., et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997, 131:47-54.
79. Hayward A.R., Levy J., Facchetti F., Notarangelo L., Ochs H.D., Etzioni A., et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997, 158:977-983.
80. Notarangelo L.D., Hayward A.R. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000, 120:399-405.
81. Gulino A.V., Notarangelo L.D. Hyper IgM syndromes. Curr Opin Rheumatol 2003, 15:422-429.
82. Powell B.R., Buist N.R., Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982, 100:731-737.
83. Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007, 120:744-750.
84. Miyara M., Gorochov G., Ehrenstein M., Musset L., Sakaguchi S., Amoura Z. Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 2011, 10:744-755.
85. Ochs H.D., Ziegler S.F., Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol Rev 2005, 203:156-164.
86. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010, 35:265-268.
87. Lyon M.F., Peters J., Glenister P.H., Ball S., Wright E. The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A 1990, 87:2433-2437.
88. Miyagawa F., Gutermuth J., Zhang H., Katz S.I. The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun 2010, 35:192-198.
89. Tang Q., Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006, 212:217-237.
90. Schurman S.H., Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 2003, 15:446-453.
91. Derry J.M., Ochs H.D., Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994, 78:635-644.
92. Notarangelo L.D., Miao C.H., Ochs H.D. Wiskott-Aldrich syndrome. Curr Opin Hematol 2008, 15:30-36.
93. Ochs H.D., Thrasher A.J. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006, 17:725-738.
94. Ozsahin H., Cavazzana-Calvo M., Notarangelo L.D., Schulz A., Thrasher A.J., Mazzolari E., et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 2008, 111:439-445.
95. Guo X., Su B., Zhou Z., Sha J. Rapid evolution of mammalian X-linked testis microRNAs. BMC Genomics 2009, 10:97.
96. Carissimi C., Fulci V., Macino G. MicroRNAs: novel regulators of immunity. Autoimmun Rev 2009, 8:520-524.
97. Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response. Autoimmun Rev, 2011 Jul 11 [Epub ahead of print].
98. Pinheiro I., Dejager L., Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences?: the X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays 2011, 33:791-802.